Americus Therapeutics is a biopharmaceutical company that has been around since 2004. This company was created in 2004 as a means to deal with rare and orphan diseases that show up in various parts of the world. Americus Therapeutics is located inside of Cranbury, New Jersey but its reach spreads around the globe. The company utilizes enzyme replacement therapies to ensure that patients are receiving the best care possible.
The rare diseases that impact people health include various things such as Epidermolysis Bullosa (EB), Pompe Diseased and Fabry Disease. They also deal with a wide range of lysosomal storage disorders which are various diseases that kill cells at the molecular level. This company also deals with individuals suffering from genetic diseases.
Americus Therapeutics employs at least 91 people and they have opened up another office inside of San Diego. The company has not produced any marketable products since 2014 (https://seekingalpha.com/article/4073303-amicus-therapeutics-small-biotech-seems-big-mo). As a result of this inactivity, they have not generated any type of revenue. Keep in mind that Amicus does not have their own manufacturing department and has outsourced its manufacturing in the past.
This company now works to connect patients, their families, various resources and organizations into one cohesive unit where people can get the help they need (ReleaseFact). Americus doesn’t focus on selling products but on the initiatives, research, and funding that will help to get results for people with rare and orphan ailments. This company is truly dedicated to this cause. Many patients who received help from this company can positively testify to their effectiveness in treating these type of conditions.